|
Phase 1 study of pembrolizumab plus chemotherapy as first-line treatment in Japanese patients with advanced NSCLC |
|
|
|
Titel: |
Phase 1 study of pembrolizumab plus chemotherapy as first-line treatment in Japanese patients with advanced NSCLC |
Auteur: |
Kurata, Takayasu Nakagawa, Kazuhiko Satouchi, Miyako Seto, Takashi Sawada, Takeshi Han, Shirong Homma, Masae Noguchi, Kazuo Nogami, Naoyuki |
Verschenen in: |
Cancer treatment and research communications |
Paginering: |
Jaargang 29 () nr. C pagina's p. |
Jaar: |
2021 |
Inhoud: |
|
Uitgever: |
Merck Sharp & Dohme Corp., The Author(s) |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|